Email updates

Keep up to date with the latest news and content from BMC Pharmacology and Toxicology and BioMed Central.

This article is part of the supplement: 6th International Conference on cGMP: Generators, Effectors and Therapeutic Implications

Open Access Poster presentation

Identification and quantitation of 2´,3´-cGMP in murine tissues

Heike Burhenne12*, Sarah Tschirner1, Roland Seifert1 and Volkhard Kaever12

Author Affiliations

1 Institute of Pharmacology, Hannover Medical School, Germany

2 Research Core Unit Mass Spectrometry - Metabolomics, Hannover Medical School, Germany

For all author emails, please log on.

BMC Pharmacology and Toxicology 2013, 14(Suppl 1):P12  doi:10.1186/2050-6511-14-S1-P12

The electronic version of this article is the complete one and can be found online at:

Published:29 August 2013

© 2013 Burhenne et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


3´,5´-cGMP is a well-known second messenger in eukaryotic cells which is synthesized by particulate and soluble guanylyl cyclases and is involved in several cardiovascular and neurological processes [1,2]. It has been recently reported that also 2´,3´-cGMP (Figure 1) can be found in high concentrations in rabbit kidney and pancreas [3]. So far, little is known about the source and biological role of 2´,3´-cGMP as well as its tissue distribution. To address this question, we have developed sensitive and specific liquid chromatography-coupled mass spectrometry (LC-MS/MS) methods for identification and quantitation of 2´,3´- nucleoside monophosphates (2´,3´-cNMPs) simultaneously with 3´,5´-cNMPs (cAMP, cCMP, cGMP, cUMP). We systematically analyzed mouse tissues (brain, thymus, heart, lung, liver, pancreas, spleen, kidney, bladder, testis, ovary, uterus) for the presence of 2’,3’- and 3’,5’-cNMPs, respectively.

thumbnailFigure 1. Chemical structures of 3’,5’-cGMP and 2’,3’-cGMP

Materials and methods

For cNMP extraction, 30-200 mg tissue was transferred to a 2.0 mL tube containing a garnet matrix and one ¼ inch ceramic sphere. An organic extraction solvent was added and tissues were homogenated in a FastPrep-24® system (MP Biomedicals, Germany). The homogenate was centrifuged and the supernatant fluid was evaporated to dryness at 40°C under a nitrogen stream. The residue pellet was resuspended in water and analyzed by LC-MS/MS.

Detection and quantitation of 2’,3’- and 3’,5’-cNMPs was performed on a tandem mass spectrometer (5500 QTRAP®; AB SCIEX, USA). We confirmed our data on a TripleTOFTM 5600 system (AB SCIEX, USA) which is characterized by an extremely high mass accuracy.


The chromatogram of a standard cNMP sample demonstrates that the LC-MS/MS method is suitable for the detection and quantitation of 2’,3’- and 3’,5’-cNMPs. Due to their retention times, all 2’,3’-cNMPs could be reliably discriminated from their 3’,5’-isomers (Figure 2A).

In addition to 3’,5’-cGMP we detected notable amounts of 2’,3’-cGMP in various mouse tissues. For example, heart samples showed an up to 5-fold higher concentration of 2’,3’-cGMP compared with the 3’,5’-cNMP (Figure 2B). In murine pancreas and spleen only 2’,3’-cGMP but no 3’,5’-cGMP could be detected.

Besides 2’,3’-cGMP, remarkably high levels of 2’,3’-cCMP and 2’,3’-cUMP were detected in murine heart, kidney, spleen, liver, pancreas and lung.

thumbnailFigure 2. A: Representative chromatogram of a 3’,5’- /2’,3’ cNMP standard (I: 2’,3’-cCMP, II: 2’,3’-cUMP, III: 3’,5’-cCMP, IV: 2’,3’-cGMP, V: 3’,5’-cUMP, VI: 3’,5’-cGMP, VII: 2’,3’-cAMP, VIII: 3’5’-cAMP) B: Detection of 2’,3’-cGMP and 3’,5’-cGMP in murine heart


2’,3’-cAMP is an mRNA degradation product. Increased 2’,3’-cAMP concentrations may play a role in cell death and cell proliferation [4].

We have demonstrated that high levels of 2’,3’-cGMP as well as 2’,3’-cCMP and 2’,3’-cUMP can be detected in various murine tissues. Our results indicate that these cNMPs play an important but still unknown role in (patho)physiological processes.

To our knowledge, this is the first time that mammalian tissues were systematically analyzed for the occurrence of 2’,3’-cNMPs. Our methods allow reliable detection and quantitation of four 2’,3’-cNMPs simultaneously with their 3’,5’-isomers and are, therefore, useful for the characterization of the physiological role of 2’,3’-cNMPs.


  1. Kots AY, Martin E, Sharina IG, Murad F: A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases.

    Handb Exp Pharmacol 2009, 191:1-14. PubMed Abstract | Publisher Full Text OpenURL

  2. Stasch JP, Pacher P, Evgenov OV: Soluble guanylate cyclases as an emerging therapeutic target in cardiopulmonary disease.

    Circulation 2011, 123:2263-2273. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  3. Van Damme T, Zhang Y, Lynen F, Sandra P: Determination of cyclic guanosine- and cyclic adenosine monophosphate (cGMP and cAMP) in human plasma and animal tissues by solid phase extraction on silica and liquid chromatography-triple quadrupole mass spectrometry.

    J Chromatogr B 2012, 909:14-21. PubMed Abstract | Publisher Full Text OpenURL

  4. Jackson EK: The 2´,3´-cAMP-adenosine pathway.

    Am J Physiol Renal Physiol 2011, 301:F1160-F1167. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL